181296-84-4 Usage
General Description
Omigapil is a synthetic compound that has shown promise in the treatment of muscle degeneration and weakening in conditions such as muscular dystrophy. It works by inhibiting the activity of an enzyme known as 15-lipoxygenase (15-LOX), which is involved in promoting inflammation and muscle damage. By reducing the levels of 15-LOX, omigapil can help to protect muscle cells from damage and improve their overall function. This potential therapeutic effect makes omigapil an important target for further research and development in the treatment of muscle degenerative diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 181296-84-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,1,2,9 and 6 respectively; the second part has 2 digits, 8 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 181296-84:
(8*1)+(7*8)+(6*1)+(5*2)+(4*9)+(3*6)+(2*8)+(1*4)=154
154 % 10 = 4
So 181296-84-4 is a valid CAS Registry Number.
InChI:InChI=1/C19H17NO/c1-3-12-20(2)14-16-13-15-8-4-6-10-18(15)21-19-11-7-5-9-17(16)19/h1,4-11,13H,12,14H2,2H3
181296-84-4Relevant articles and documents
COUMPOUNDS MODULATING THE ACTIVITY OF GAPDH AND/OR IAMT
-
Page 38, (2010/02/06)
Novel compounds and their use for modulationof L-Isoaspartyl (D-Aspartyl) 0-Metyltransferase and/or glyceraldehyde-3-phosphate dehydrogenase activity enable the prevention treatment or alleviation of diabetes, autoimmune diseases and neuro-degenerative diseases.. Compounds are of any of the formulae I - IV below:
